Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CG Oncology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CGON
Nasdaq
8731
https://www.cgoncology.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CG Oncology Inc
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
- Apr 26th, 2024 12:00 pm
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
- Apr 24th, 2024 2:00 pm
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
- Mar 28th, 2024 12:00 pm
CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer
- Feb 27th, 2024 1:00 pm
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Jan 30th, 2024 12:00 pm
CG Oncology Announces Pricing of Upsized Initial Public Offering
- Jan 25th, 2024 12:10 am
Scroll